NFKB1 and acute myeloid leukemia: found that venetoclax directly activates Natural killer (NK) cells, enhancing their cytotoxicity against acute myeloid leukemia (AML) both in vitro and in vivo, and venetoclax promotes mitochondrial respiration and ATP synthesis via the NF-κB pathway, thereby facilitating immunological synapse (IS) formation in NK cells (4).